BioCryst Announces Presentation of Fodosine Data During the 47th Annual Meeting and Exposition of the American Society Of Hematology
12th Dec 2005, 15:35 GMT
BioCryst Pharmaceuticals provided an informational update summarizing highlights from 3 presentations related to the clinical development of Fodosine, its lead product candidate for the treatment of certain leukemias and lymphomas, presented at the 47th Annual Meeting and Exposition of the American Society of Hematology being held from December 10-13 in Atlanta, GA.
BioCryst Announces Presentation of Fodosine Data During the 47th Annual Meeting and Exposition of the American Society Of Hematology related news:
- Ascenta AT-101 Data Presented at the American Society of Hematology 47th Annual Meeting and Exposition in Atlanta, GA — Bio-Technology News from StratCenter.com
- Dacogen Injection Data Presented at American Society of Hematology Annual Meeting — Laboratory News from StratCenter.com
- REVLIMID Clinical Results as Oral Treatment Regimen in Myelofibrosis Presented at the 47th American Society of Hematology Meeting — Laboratory News from StratCenter.com
- Ascenta AT-101 Data Presented at the American Society of Hematology 47th Annual Meeting and Exposition in Atlanta, Georgia — PR Newswire: All Releases
- REVLIMID Clinical Results as Oral Treatment Regimen in Chronic Lymphocytic Leukemia Presented at the 47th American Society of Hematology Meeting — Laboratory News from StratCenter.com
- SGX Pharmaceuticals Presenting Data at American Society of Hematology Annual Meeting on Inhibitors of Wild-Type and Gleevec Resistant BCR-ABL Kinase — Laboratory News from StratCenter.com
- REVLIMID Clinical Results as Oral Treatment Regimen in Newly Diagnosed Multiple Myeloma Presented at the 47th American Society of Hematology Meeting — Pharmaceuticals News from StratCenter.com
- Clinical Data Highlighting Thalidomide Use in Newly Diagnosed, Previously Treated and Relapsed Multiple Myeloma Patients Presented at 47th Annual Meeting of the American Society of Hematology — PR Newswire: All Releases
- ZymoGenetics Announces Presentation of TACI-Ig Phase 1 Preliminary Findings in Multiple Myeloma at American Society of Hematology Meeting — Radiology News from StratCenter.com
- Genentech contributes $500,000 to support ASH's Minority Medical Student Award Program — EurekAlert! - Medicine and Health
Latest news from Laboratory News from StratCenter.com:
- Abstract Evaluating QUADRAMET for Multiple Myeloma Presented erican Society of Hematology Annual Meeting
- QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
- Stratagene Reports Q3 Results
- Viking Systems Appoints Dr Michael Manyak to Its Board
- Soliant Health To Exhibit at the American Speech-Language-Hearing Assoc Conference
- Sysmex America Awarded Contract to Service VA Med Cntrs in Midwest States
- Ronald D Luff, MD, Recognized By the American Society of Cytopathology for Groundbreaking Work in Diagnosis of Cervical Disease
- INNOVIVE Pharmaceuticals Reports Q3 Results
- Launch of 'Egg Banking' Program Breaks New Ground as 1st Program of Its Kind in NC
- Global Care Quest Announces ICIS 5